252 related articles for article (PubMed ID: 32872372)
1. Involvement of STAT5 in Oncogenesis.
Halim CE; Deng S; Ong MS; Yap CT
Biomedicines; 2020 Aug; 8(9):. PubMed ID: 32872372
[TBL] [Abstract][Full Text] [Related]
2. STAT proteins as novel targets for cancer drug discovery.
Turkson J
Expert Opin Ther Targets; 2004 Oct; 8(5):409-22. PubMed ID: 15469392
[TBL] [Abstract][Full Text] [Related]
3. Activation of STAT5 triggers proliferation and contributes to anti-apoptotic signalling mediated by the oncogenic Xmrk kinase.
Morcinek JC; Weisser C; Geissinger E; Schartl M; Wellbrock C
Oncogene; 2002 Mar; 21(11):1668-78. PubMed ID: 11896598
[TBL] [Abstract][Full Text] [Related]
4. Differential constitutive activation between STAT-related proteins and MAP kinase in primary acute myelogenous leukaemia.
Hayakawa F; Towatari M; Iida H; Wakao H; Kiyoi H; Naoe T; Saito H
Br J Haematol; 1998 Jun; 101(3):521-8. PubMed ID: 9633897
[TBL] [Abstract][Full Text] [Related]
5. Energy Metabolism in Cancer: The Roles of STAT3 and STAT5 in the Regulation of Metabolism-Related Genes.
Valle-Mendiola A; Soto-Cruz I
Cancers (Basel); 2020 Jan; 12(1):. PubMed ID: 31947710
[TBL] [Abstract][Full Text] [Related]
6. Diagnostic utility of phosphorylated signal transducer and activator of transcription 5 immunostaining in the diagnosis of mammary analogue secretory carcinoma of the salivary gland: A comparative study of salivary gland cancers.
Kawahara A; Taira T; Abe H; Takase Y; Kurita T; Sadashima E; Hattori S; Imamura I; Matsumoto S; Fujisaki H; Sueyoshi K; Akiba J; Kage M
Cancer Cytopathol; 2015 Oct; 123(10):603-11. PubMed ID: 26252941
[TBL] [Abstract][Full Text] [Related]
7. The genes induced by signal transducer and activators of transcription (STAT)3 and STAT5 in mammary epithelial cells define the roles of these STATs in mammary development.
Clarkson RW; Boland MP; Kritikou EA; Lee JM; Freeman TC; Tiffen PG; Watson CJ
Mol Endocrinol; 2006 Mar; 20(3):675-85. PubMed ID: 16293640
[TBL] [Abstract][Full Text] [Related]
8. Formononetin-induced oxidative stress abrogates the activation of STAT3/5 signaling axis and suppresses the tumor growth in multiple myeloma preclinical model.
Kim C; Lee SG; Yang WM; Arfuso F; Um JY; Kumar AP; Bian J; Sethi G; Ahn KS
Cancer Lett; 2018 Sep; 431():123-141. PubMed ID: 29857127
[TBL] [Abstract][Full Text] [Related]
9. Jak3, STAT3, and STAT5 inhibit expression of miR-22, a novel tumor suppressor microRNA, in cutaneous T-Cell lymphoma.
Sibbesen NA; Kopp KL; Litvinov IV; Jønson L; Willerslev-Olsen A; Fredholm S; Petersen DL; Nastasi C; Krejsgaard T; Lindahl LM; Gniadecki R; Mongan NP; Sasseville D; Wasik MA; Iversen L; Bonefeld CM; Geisler C; Woetmann A; Odum N
Oncotarget; 2015 Aug; 6(24):20555-69. PubMed ID: 26244872
[TBL] [Abstract][Full Text] [Related]
10. STAT5 in Cancer and Immunity.
Rani A; Murphy JJ
J Interferon Cytokine Res; 2016 Apr; 36(4):226-37. PubMed ID: 26716518
[TBL] [Abstract][Full Text] [Related]
11. Differential activation of signal transducer and activator of transcription (STAT)3 and STAT5 and induction of suppressors of cytokine signalling in T(h)1 and T(h)2 cells.
Anderson P; Sundstedt A; Li L; O'Neill EJ; Li S; Wraith DC; Wang P
Int Immunol; 2003 Nov; 15(11):1309-17. PubMed ID: 14565929
[TBL] [Abstract][Full Text] [Related]
12. Reciprocal effects of STAT5 and STAT3 in breast cancer.
Walker SR; Nelson EA; Zou L; Chaudhury M; Signoretti S; Richardson A; Frank DA
Mol Cancer Res; 2009 Jun; 7(6):966-76. PubMed ID: 19491198
[TBL] [Abstract][Full Text] [Related]
13. Signal transducer and activator of transcription 5 activation is sufficient to drive transcriptional induction of cyclin D2 gene and proliferation of rat pancreatic beta-cells.
Friedrichsen BN; Richter HE; Hansen JA; Rhodes CJ; Nielsen JH; Billestrup N; Møldrup A
Mol Endocrinol; 2003 May; 17(5):945-58. PubMed ID: 12586844
[TBL] [Abstract][Full Text] [Related]
14. Pharmacological Inhibition of Oncogenic STAT3 and STAT5 Signaling in Hematopoietic Cancers.
Brachet-Botineau M; Polomski M; Neubauer HA; Juen L; Hédou D; Viaud-Massuard MC; Prié G; Gouilleux F
Cancers (Basel); 2020 Jan; 12(1):. PubMed ID: 31963765
[TBL] [Abstract][Full Text] [Related]
15. Constitutive activation of STAT3 in breast cancer cells: A review.
Banerjee K; Resat H
Int J Cancer; 2016 Jun; 138(11):2570-8. PubMed ID: 26559373
[TBL] [Abstract][Full Text] [Related]
16. Mechanisms of disease: Insights into the emerging role of signal transducers and activators of transcription in cancer.
Haura EB; Turkson J; Jove R
Nat Clin Pract Oncol; 2005 Jun; 2(6):315-24. PubMed ID: 16264989
[TBL] [Abstract][Full Text] [Related]
17. Signalling by the oncogenic receptor tyrosine kinase Xmrk leads to activation of STAT5 in Xiphophorus melanoma.
Wellbrock C; Geissinger E; Gómez A; Fischer P; Friedrich K; Schartl M
Oncogene; 1998 Jun; 16(23):3047-56. PubMed ID: 9662338
[TBL] [Abstract][Full Text] [Related]
18. Activation of STAT3 and STAT5 Signaling in Epithelial Ovarian Cancer Progression: Mechanism and Therapeutic Opportunity.
Wu CJ; Sundararajan V; Sheu BC; Huang RY; Wei LH
Cancers (Basel); 2019 Dec; 12(1):. PubMed ID: 31861720
[No Abstract] [Full Text] [Related]
19. Stat5 in the mammary gland: controlling normal development and cancer.
Barash I
J Cell Physiol; 2006 Nov; 209(2):305-13. PubMed ID: 16883580
[TBL] [Abstract][Full Text] [Related]
20. Growth hormone- and prolactin-induced proliferation of insulinoma cells, INS-1, depends on activation of STAT5 (signal transducer and activator of transcription 5).
Friedrichsen BN; Galsgaard ED; Nielsen JH; Møldrup A
Mol Endocrinol; 2001 Jan; 15(1):136-48. PubMed ID: 11145745
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
